Back

Apabetalone (RVX-208) impacts key biomarkers and pathways associated with cardiovascular disease in patients with severe renal impairment

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 7 - CAD and comorbidities CAD and comorbidities ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Ewelina Kulikowski

Calgary (Canada)

69 More presentations in this session

Presentation thumbnail
The impact of patterns of long-term conditions on survival among patients with acute myocardial infarction: a national cohort study of 693,333 patients
Professor C. Gale (Leeds, GB)
Presentation thumbnail
Association between optimal guideline-indicated care and survival in patients with acute myocardial infarction and long-term conditions: a population based cohort study.
Professor C. Gale (Leeds, GB)
Presentation thumbnail
Early risk stratification of patients with positive troponin and without acute coronary syndrome.
Doctor G. Cediel Calderon (Tarragona, ES)
Abstract
Presentation thumbnail
Omic and functional approaches reveal a deleterious impact of hypercholesterolemia in HDL particle remodelling
Miss S. BenAicha Gonzalez (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Low T3 syndrome is associated with higher rates of in-hospital cardiac death in patients with acute myocardial infarction
Doctor W. Su (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - CAD and comorbidities

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources